TikTok has formed a nine-member Safety Advisory Council in Europe to help shape its content moderation policies and practices
When she first arrived in Albany to work as a legislative aide in 2013, New York Assembly Member Yuh-Line Niou had lawmakers grab her buttocks, suggest she and her boss were “a hot duo” who should have sex, and peer into her office to check her out for a “hot or not” list.
A Tuesday morning fire left a giant hole in the roof of a Durham apartment. Officials tell ABC11 no one was hurt.
The "North America Bottled Water Market By Product (purified water, mineral water, spring water, sparkling water, distilled water, and other products), By Country, Industry Analysis and Forecast, 2020 - 2026" report has been added to ResearchAndMarkets.com's offering.
Grown Rogue International Inc. ("Grown Rogue" or the "Company") (CSE: GRIN) (OTC: GRUSF), a multi-state cannabis company with profitable operations and assets in Oregon and Michigan, has released its financial and operating results for the year ended October 31, 2020. The Company’s business strategy focuses on production efficiencies, driving higher margin product sales, and strategic acquisitions of distressed assets. Grown Rogue achieved positive Adjusted EBITDA1 for the year ending October 31, 2020, with Cash Margin for Grown Rogue products2 reaching 62%. Total Pro Forma revenue3 including results for our Michigan operation was $6.3M, with Pro Forma Adjusted EBITDA3 of $846K.
Seneca Growth Capital VCT Plc (the "Company") 2 March 2021 Issue of Equity and Total Voting Rights The Company announces that it has today allotted and issued 853,114 new B ordinary shares of 1p each in the Company (“B Shares”). The shares were issued pursuant to an offer for subscription for B Shares launched on 13 October 2020 to raise, in aggregate, up to £10 million with an over-allotment facility of up to a further £10 million (before issue costs) (the "Offer"). Pursuant to the Offer, and the £854,500 of valid applications received since 7 December 2020 (the cut-off date for the last allotment of shares made on 9 December 2020), and up to and including 26 February 2021 in respect of the 2020/2021 tax year, the Company has today allotted and issued 853,114 B Shares. In accordance with the allotment formula set out in the prospectus for the Offer, the B Shares have been allotted at the offer prices in the range of 99.4p to 105.2p per share, calculated by reference to the unaudited net asset value of a B Share as at 19 February 2021 (99.4p per B Share as announced on 23 February 2021). As a result of this allotment, the number of shares now in issue is 8,115,376 ordinary shares of 1p each and 9,916,062 B Shares. Therefore, the total number of voting rights in the Company is 18,031,438. In respect of this allotment, an application will be made by the Company to the Financial Conduct Authority and to the London Stock Exchange for the B Shares so issued to be admitted to the Official List and to trading on the London Stock Exchange's main market for listed securities. It is expected that the admission of the B Shares will become effective and dealings will commence on or around 8 March 2021. The above statement of voting capital may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules. This announcement contains inside information as stipulated under the UK version of the Market Abuse Regulation No 596/2014 which is part of English law by virtue of the European (Withdrawal) Act 2018, as amended. On publication of this announcement via a regulatory information service, this information is considered to be in the public domain. For further information, please contact: John Hustler, Seneca Growth Capital VCT Plc at firstname.lastname@example.org Richard Manley, Seneca Growth Capital VCT Plc at Richard.Manley@senecapartners.co.uk Any enquiries in respect of the Offer should be directed to: John DaviesSeneca Partners Limited01942 295 981John.Davies@senecapartners.co.uk
Global Food Wrapping Paper Market 2021-2025 The analyst has been monitoring the food wrapping paper market and it is poised to grow by $ 830. 20 mn during 2021-2025 progressing at a CAGR of 4% during the forecast period.New York, March 02, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Food Wrapping Paper Market 2021-2025" - https://www.reportlinker.com/p05796200/?utm_source=GNW Our report on food wrapping paper market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing demand for sustainable food packaging and rise in food delivery and takeaway market. In addition, growing demand for sustainable food packaging is anticipated to boost the growth of the market as well.The food wrapping paper market analysis includes type segment and geographical landscapes.The food wrapping paper market is segmented as below:By Type• Kraft paper• Greaseproof paper• Coated paperBy Geographical Landscapes• North America• Europe• APAC• MEA• South AmericaThis study identifies the growth of fast food market as one of the prime reasons driving the food wrapping paper market growth during the next few years.The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on food wrapping paper market covers the following areas:• Food wrapping paper market sizing• Food wrapping paper market forecast• Food wrapping paper market industry analysisThis robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading food wrapping paper market vendors that include Advanced Coated Products Ltd., Alpha Carbonless Paper Mfg. Co. Pvt. Ltd., Amcor Plc, Anchor Packaging Inc., Constantia Flexibles Group GmbH, delfortgroup AG, Sappi Ltd., Seaman Paper Co., Twin Rivers Paper Co. Inc., and WestRock Co.. Also, the food wrapping paper market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.Read the full report: https://www.reportlinker.com/p05796200/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: email@example.com US: (339)-368-6001 Intl: +1 339-368-6001
Management to provide corporate update on Dermal Sciences and BioSurgeryFRAMINGHAM, Mass., March 02, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), innovator of AC5® Advanced Wound System and other self-assembling Dermal Sciences and BioSurgery devices, announced today that it will be presenting at the H.C. Wainwright Global Life Sciences Conference, which will be held March 9-10, 2021. Chief Executive Officer, Terrence W. Norchi, MD, and Chief Financial Officer, Richard Davis, are scheduled to present via webcast and be available for meetings. The webcast will be available on-demand starting at 7:00 A.M. EST, Tuesday, March 9, 2021. You may access the live webcast by clicking here: webcast. Attendees may find conference information and register for meetings with management by clicking here: information. After the event, the presentation may be accessed through the Company’s website by clicking here: presentation. About Arch Therapeutics, Inc.Arch Therapeutics, Inc. is a biotechnology company developing a novel approach to stop bleeding (hemostasis), control leaking (sealant) and manage wounds during surgery, trauma and interventional care. Arch is developing products based on an innovative self-assembling barrier technology platform with the goal of making care faster and safer for patients. Arch has received regulatory authorization to market AC5® Advanced Wound System and AC5® Topical Hemostat as medical devices in the United States and Europe, respectively. Arch's development stage product candidates include AC5-G™, AC5-V® and AC5® Surgical Hemostat, among others.1,2 Notice Regarding Forward-Looking StatementsThis news release contains "forward-looking statements" as that term is defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, references to novel technologies and methods, our business and product development plans and projections, or market information. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with developing new products or technologies and operating as a development stage company, our ability to retain important members of our management team and attract other qualified personnel, our ability to raise the additional funding we will need to continue to pursue our business and product development plans, our ability to obtain required regulatory approvals, our ability to produce commercial quantities of our products within projected timeframes, our ability to develop and commercialize products based on our technology platform, and market conditions, and our ability to establish additional commercialization partnerships and build a critical mass of field sales representatives. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in the reports and other documents we file with the SEC, available at www.sec.gov. 1 AC5-G, AC5-V, and AC5 Surgical Hemostat are currently investigational devices limited by law to investigational use.2 AC5, AC5-G, AC5-V and associated logos are trademarks and/or registered trademarks of Arch Therapeutics, Inc. and/or its subsidiaries. Source: Arch Therapeutics, Inc. ContactARTH Investor RelationsToll Free: +1-855-340-ARTH (2784) (US and Canada)Email: firstname.lastname@example.org Website: www.archtherapeutics.com or Richard DavisChief Financial OfficerArch Therapeutics, Inc.Phone: 617-431-2308Email: email@example.comWebsite: www.archtherapeutics.com
Form 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION Name of person dealing (Note 1)Invesco Ltd.Company dealt inWillis Towers Watson plcClass of relevant security to which the dealings being disclosed relate (Note 2)Ordinary Shares IE00BDB6Q211Date of dealing01-03-2021 INTERESTS AND SHORT POSITIONS Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) LongShort Number (%)Number (%)(1) Relevant securities1,444,397 1.119% 2,900 0.002%(2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total1,444,397 1.119% 2,900 0.002% Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) Class of relevant security:LongShort No. (%)Number (%)(1) Relevant securities (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total DEALINGS (Note 4) Purchases and sales Purchase/sale Number of relevant securities Price per unit (Note 52Purchase152226.72 USDSale189226.72 USD (b) Derivatives transactions (other than options transactions) Product name, e.g. CFDNature of transaction (Note 6)Number of relevant securities (Note 7)Price per unit (Note 5) (c) Options transactions in respect of existing relevant securities (i) Writing, selling, purchasing or varying Product name,e.g. call optionWriting, selling, purchasing, varying etc.Number of securities to which the option relates (Note 7)Exercise priceType, e.g. American, European etc.Expiry dateOption money paid/received per unit (Note 5) (ii) Exercising Product name, e.g. call optionNumber of securitiesExercise price per unit (Note 5) (d) Other dealings (including transactions in respect of new securities) (Note 4) Nature of transaction (Note 8)DetailsPrice per unit (if applicable) (Note 5) 2. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. Is a Supplemental Form 8 attached? (Note 9) NO Date of disclosure02-03-2021Contact namePhilippa HolmesTelephone number+44 1491 417447If a connected EFM, name of offeree/offeror with which connectedN/AIf a connected EFM, state nature of connection (Note 10)
The GMB presenter revealed what has helped her get through this 'grimmest of times' as her husband reaches a year of hospitalisation.
St John “passed away peacefully with his family at his bedside” on Monday evening.
The "Severe Toxicities in Lymphoma - Market Insight, Epidemiology and Market Forecast - 2030" drug pipelines has been added to ResearchAndMarkets.com's offering.
The "Phase Change Memory - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Mar. 2—The Pennsylvania Department of Transportation (PennDOT) has committed $452.7 million in liquid fuels payments to help certified municipalities maintain their roads and bridges. This year's allocation is approximately 7% less than last year's, due to reduced gas tax revenues as a result of COVID-19. "We have the fifth-largest state-maintained road system in the country, and there are ...
Global media watchdog Reporters Without Borders (RSF) has accused Saudi Arabia's Crown Prince Mohammed bin Salman and several top officials of committing crimes against humanity in a criminal complaint filed in Germany. The 500-page complaint, filed on Monday with the German Public Prosecutor General in the Karlsruhe federal court, includes allegations of arbitrary detention of more than 30 journalists and the murder of Washington Post columnist Jamal Khashoggi in the Saudi consulate in Istanbul in 2018. Prince Mohammed has denied any involvement in Khashoggi's killing.
Cold War spy drama “Baloton Brigade” has been selected to pitch at Series Mania in Lille as part of the Berlinale-Series Mania Project Exchange. Under the terms of the partnership, now in its seventh year, one project pitched at Series Mania at Lille is invited to pitch again at the ongoing Berlin Series Market’s Co-Pro […]
Trench T21-26 intersected 34.5 m at 5.59 g/t goldLONGUEUIL, Quebec, March 02, 2021 (GLOBE NEWSWIRE) -- Reunion Gold Corporation (TSX-V: RGD) (the "Company") is pleased to report results from six additional trenches of its ongoing exploration program at its Oko West Project in Guyana. The best intercepts are listed below, confirming the discovery of significant gold mineralization. Table 1: Significant trench intercepts (also see Figure 2) Trench ID From (m)To (m)Length (m)Gold (g/t)T21-024 82842.005.74 981002.001.74 1201222.001.24T21-025 62642.002.39 7273.51.500.54T21-026 8168.001.11 incl.10144.001.80 3670.534.505.59 incl.426018.003.32 incl.6061.51.5061.03 incl.61.567.56.002.13 incl.67.5691.5015.82 849410.000.48 981046.000.88 incl.1001044.001.08T21-027 1501522.000.58T21-028 14.73.700.62T21-029 54562.001.95 9811618.000.76 incl.1081102.002.77 1261326.000.58 1521542.001.74 These six trenches have a total length of 640 meters and 347 channel samples were taken. On December 9, 2020, the Company had reported the assay results from 19 trenches completed at Oko West in 2020. So far, results from 25 trenches with a combined length of approximately 2,700 meters have been released. The ongoing trenching program continues to expand the footprint of three mineralized shear zones discovered in 2020, and the Company plans to test the entire 6-km long geochemical gold anomaly coinciding with a granite and volcanic contact (Figure 1). Gold mineralization is found in north-south shear zones straddling the contact of weathered granitic and volcanic rocks (Figure 2), with frequent intercalation of lithological units, and associated with quartz veining and alteration minerals like pyrite and sericite. On February 18, 2021, the Company had reported assay results from its initial 1,000-meter diamond drilling program at Oko West. The Company also plans to conduct another diamond drilling campaign to test the encouraging gold mineralization found in the trenches further in the year. Oko West is part of a group of permits in the Cuyuni River basin covering an area of 9,420 acres where the Company has an option to acquire a 100% ownership interest. Sample collection, assaying and data management Channel samples were taken horizontally and continuously in in-situ weathered rocks (saprolite) at regular intervals on trench walls. Reunion considers channel samples as sub-horizontal "drill holes" given their continuity and representative rock mass. Samples were sealed in plastic bags and shipped to the Actlabs certified laboratory in Georgetown, Guyana, respecting the best chain of custody practices. At the laboratory, samples were dried, crushed up to 80% passing 2 mm, riffle split (250 g), and pulverized to 95% passing 105 μm, including cleaner sand. 50 g of pulverized material is fire assayed by atomic absorption (AA). Initial assays with results above 3,000 ppb gold are re-assayed with gravimetric finish. Assay data is subject to QA/QC using acQuire software and management by an independent consultant. Qualified Person The technical information in this press release has been reviewed and approved by Carlos. H. Bertoni, P.Geo., the Company's Acting CEO. Mr. Bertoni is a qualified person under Canadian National Instrument 43-101. Cautionary Statement This press release contains certain forward-looking information or forward-looking statements as defined in applicable securities laws. Forward-looking statements are not historical facts and are subject to several risks and uncertainties beyond the Company's control, including statements regarding plans to complete trenching, drilling and other exploration programs, potential mineralization, exploration results and statements regarding beliefs, plans, expectations or intentions of the Company. Resource exploration and development is highly speculative, characterized by several significant risks, which even a combination of careful evaluation, experience and knowledge may not eliminate. All forward-looking statements herein are qualified by this cautionary statement. Accordingly, readers should not place undue reliance on forward-looking statements. The Company undertakes no obligation to update publicly or otherwise revise any forward-looking statements whether as a result of new information or future events or otherwise, except as may be required by law. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this press release. About Reunion Gold Reunion Gold Corporation is a leading gold explorer in the Guiana Shield, South America, with a portfolio of projects in Guyana, Suriname and French Guiana. The Company's common shares are listed on the TSX Venture Exchange under the symbol 'RGD.' Additional information about the Company is available on SEDAR (www.sedar.com) and the Company's website (www.reuniongold.com). For further information, please contact:REUNION GOLD CORPORATION Carlos H. Bertoni, acting CEO orPaul Fowler, Manager, Corporate DevelopmentTelephone: +1 450.677.2585Email: firstname.lastname@example.org Figure 1: Map of Oko West project area schematic geology, permits outlines and shear zones discovered (red dashed lines). The map also shows a soil geochemical grid underway to test the volcanic / granitoid contact in the southern part of the project area. Figure 2: Map of the Oko West easternmost portion of the project area, showing schematic geology, trench and drill sampling results (*), and mineralized shear zones discovered. Trench results in this press released are highlighted in yellow. (*) Composites calculated using these parameters: Minimum composite grade: 0.4 g/tMinimum composite length: 2 mCut-off of an interval to be included in composite: 0.4 g/tThe maximum length of internal waste: 2 m
Mar. 2—MONTCALM — Mercer County deputies were continuing their search Monday for a person of interest connected with a shooting reported early Saturday morning in the Montcalm community. The Mercer County Sheriff's Department was looking for Scotty Tiller, no age of available, of Montcalm, according to Chief Deputy Joe Parks. Tiller had not been located as of Monday. Parks said Saturday that ...
Mar. 2—WELCH — Flooding and high water seen Monday morning in southern West Virginia and Southwest Virginia started receding by the early afternoon while forecasters predicted a break from the rain starting today. The National Weather Service in Blacksburg, Va. issued a flood warning was in effect until midnight for Mercer and Summers counties in West Virginia and in Tazewell, Va. In McDowell ...
Mar. 2—PRINCETON — West Virginia Division of Highways crews in the southern counties and across the state are taking advantage of the earliest sign of spring weather and getting a jump on repairing the roadway damage winter left behind. Asphalt plants have started opening in West Virginia and transportation workers were ready. WVDOH officials said Monday. District 10 Engineer Joe Pack, ...